Clinical Trials in the MENA Region In-house Training

This course examines the MENA region’s growing role in clinical trials, driven by its diverse population, rising chronic disease rates, and supportive regulatory environment. More details...

Questions?
Contact Harry about this course, or call us on +44 7749 4749

Live online

  • 09:00 - 17:15 UK (London) (UTC+00)
  • 10:00 - 18:15 Paris (UTC+01)
  • 04:00 - 12:15 New York (UTC-05)

Course code 16835


£649 / €909 / $1,043

Pricing details: multiple places, early booking discounts

View basket 

Live online

  • 09:00 - 17:15 UK (London) (UTC+01)
  • 10:00 - 18:15 Paris (UTC+02)
  • 04:00 - 12:15 New York (UTC-04)

Course code 17139


3rd place FREE

£649 / €909 / $1,043

Pricing details: multiple places, early booking discounts

View basket 

Live online

  • 09:00 - 17:15 UK (London) (UTC+00)
  • 10:00 - 18:15 Paris (UTC+01)
  • 04:00 - 12:15 New York (UTC-05)

Course code 17476


3rd place FREE

£649 / €909 / $1,043

Pricing details: multiple places, early booking discounts

View basket 

Tailored to your team's requirements, at your choice of location or online.


From

£500

Per delegate, based on 10 delegates and a duration of 1 day


Contact our in-house team

Course overview

This course focuses on the MENA region which offers various opportunities for clinical trial market studies. It's diverse and rapidly growing population is ideal for studying treatment efficacy across different demographics. This diversity can significantly contribute to the global understanding of diseases and enhance the generalizability of clinical trial outcomes.

Additionally, the rising prevalence of chronic diseases in the MENA region, such as cancer, diabetes, and cardiovascular disorders, result in increased research efforts to address the growing healthcare issues.

Regulatory authorities in the region are committed to ensuring the safety, efficacy, and quality of medical products, ultimately improving patient access to essential treatments.

Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.

Benefits of attending

  • Gain a clear understanding of the opportunities and progression in clinical trial studies by some selected countries in the MENA region
  • Comprehend the regulatory advancements across the region
  • Learn about each country's unique approaches to aligning with international standards and leveraging reliance practices to streamline regulatory processes
  • Understand the opportunities and progress in clinical trial studies in selected MENA countries, touching on the regulatory advancements across the region

Who should attend

  • Clinical project managers
  • Clinical Research Associates (CRAs)
  • Trial managers
  • Regulatory Affairs managers
  • Regional regulatory strategists
  • Project managers
  • Medical directors
  • Business directors

This course will cover:

General introduction

  • Healthcare systems
  • Pharmaceutical market
  • Clinical trial infrastructure market
    • Stakeholders, roles and responsibilities

Economic overview

Egypt

Saudi Arabia

UAE

Qatar/Oman/Bahrain

Lebanon

Jordan

Iran

Algeria

Tunisia

Morocco

Ilona Putz
PULONA Emerging Markets

Ilona Putz is the founder and General Manager of PULONA Emerging Markets based in the UAE since 2008. Her company is dedicated to creating and developing tailor-made business concepts including regulatory consultancy for international manufacturers in the healthcare sector across the Middle East. Ilona has worked in the Pharmaceutical Industry since 1988 for companies like MSD, SmithKline Beecham, Karl Engelhard, HEXAL and Sandoz where she was the Regional Head, Middle East, for Sandoz International, Germany, responsible for all commercial and business development activities. She also consults for RegAff, Emergo and Dr. Regenold GmbH for the Middle East. Ilona spoke during the DIA Europe Meeting on “Clinical Trials in the Middle East” and at the Global Pharmaceutical Regulatory Affairs Summit 2021 and 2022. Moreover, Ilona published articles in the Journal of Medical Device Regulations on the regulatory overview for Medical Devices in Egypt, Kuwait and the UAE. 

More details

Heba Hashem
MERAS

Heba has been working with Regulatory Affairs in the Middle East for more than 25 years. She has a Pharmaceutical and Business background being a graduate of the Faculty of Pharmacy (Cairo University), RAC certified in addition to an MBA at Maastricht School of Business. For the past 20 years Heba held the position of Middle East & Africa Regulatory and Quality Head at different Pharmaceutical and Medical Device companies; Gambro, Bayer and Novo Nordisk.

Heba is now the Middle East and Africa Associate Director at PPD where she is providing regulatory consulting services and training to Health Care companies.

More details

Run Clinical Trials in the MENA Region Live online for your team

1 day

Typical duration

Pricing from:

  • GBP 500
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our team to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to our team to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Harry Altamont

Harry
ALTAMONT

Aleksandra Beer

Aleksandra
BEER

+44 (0)20 7749 4749

inhouse@ipiacademy.com